Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a …
T Johkoh, KS Lee, M Nishino, WD Travis, JH Ryu… - Radiology, 2021 - pubs.rsna.org
Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A …
T Johkoh, KS Lee, M Nishino, WD Travis, JH Ryu… - Chest, 2021 - europepmc.org
Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A …
T Johkoh, KS Lee, M Nishino, WD Travis… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A …
T Johkoh, KS Lee, M Nishino, WD Travis, JH Ryu… - …, 2021 - snucm.elsevierpure.com
Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors A …
T Johkoh, KS Lee, M Nishino, WD Travis, JH Ryu… - …, 2021 - scholarworks.bwise.kr
Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A …
T Johkoh, KS Lee, M Nishino, WD Travis… - …, 2021 - mayoclinic.elsevierpure.com
Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
Chest ct diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position …
T Johkoh, KS Lee, M Nishino, WD Travis, JH Ryu… - 2021 - cabidigitallibrary.org
Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A …
T Johkoh, KS Lee, M Nishino, WD Travis, JH Ryu… - …, 2021 - publicatt.unicatt.it
Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
[HTML][HTML] Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint …
T Johkoh, KS Lee, M Nishino, WD Travis, JH Ryu… - Radiology, 2021 - pubs.rsna.org
Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A …
T Johkoh, KS Lee, M Nishino, WD Travis, JH Ryu… - Chest, 2021 - Elsevier
Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …
the frequency and broadened the spectrum of lung toxicity, particularly in patients with …